Recent Quotes View Full List My Watchlist Create Watchlist Indicators DJI Nasdaq Composite SPX Gold Crude Oil EL&P Market Index Markets Stocks ETFs Tools Overview News Currencies International Treasuries Marker Therapeutics Highlights Its Technology During a WBB Research Institute Webinar on CAR-T and Other Cell Therapies By: Newsfile August 17, 2023 at 09:03 AM EDT Cranford, New Jersey--(Newsfile Corp. - August 17, 2023) - Marker Therapeutics (NASDAQ: MRKR) highlights its technology during a recently held, 75-minute Demi-Colton Virtual Salon/Webinar on cell therapy and CAR-T, a breakthrough cancer treatment that modifies a patient's own T cells to fight cancer. To view the full announcement, including downloadable images, bios, and more, click here. Key Takeaways: WBB Securities, an investment bank specializing in biotechnology, medical devices and life sciences, successfully organized a webinar focusing on the potential of Chimeric Antigen Receptor T-Cells (CAR-T) therapy in the future of cancer treatment. The webinar, organized by CEO Steve Brozak, DMH featured distinguished speakers and experts in the field of CAR-T Cell therapy who provided insights into the science behind the therapy, its clinical applications, and potential market growth. The positive response to the event underscores WBB Securities' role in connecting investors with key developments in the healthcare industry and a growing interest in CAR-T Cell therapy among the investor community. Click image above to view full announcement. WBB Securities The WBB Research Institute is a research organization, founded by WBB Securities. The Institute focuses on emerging critical issues in healthcare that threaten to have profound impact. WBB Securities is a leading Investment Management, Investment Banking, and Equity Research firm focused on the life sciences. WBB Securities is registered with the SEC as a broker-dealer, a FINRA member firm, and a Registered Investment Advisor with a proprietary trading desk. The firm is comprised of a nationwide team of respected senior investment and research professionals serving institutional and high-net-worth clients. Contacts: Henry Bassman 9085229212 hbassman@wbbsec.com Source: WBB Securities To view the source version of this press release, please visit https://www.newsfilecorp.com/release/177588 Data & News supplied by www.cloudquote.io Stock quotes supplied by Barchart Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions.
Marker Therapeutics Highlights Its Technology During a WBB Research Institute Webinar on CAR-T and Other Cell Therapies By: Newsfile August 17, 2023 at 09:03 AM EDT Cranford, New Jersey--(Newsfile Corp. - August 17, 2023) - Marker Therapeutics (NASDAQ: MRKR) highlights its technology during a recently held, 75-minute Demi-Colton Virtual Salon/Webinar on cell therapy and CAR-T, a breakthrough cancer treatment that modifies a patient's own T cells to fight cancer. To view the full announcement, including downloadable images, bios, and more, click here. Key Takeaways: WBB Securities, an investment bank specializing in biotechnology, medical devices and life sciences, successfully organized a webinar focusing on the potential of Chimeric Antigen Receptor T-Cells (CAR-T) therapy in the future of cancer treatment. The webinar, organized by CEO Steve Brozak, DMH featured distinguished speakers and experts in the field of CAR-T Cell therapy who provided insights into the science behind the therapy, its clinical applications, and potential market growth. The positive response to the event underscores WBB Securities' role in connecting investors with key developments in the healthcare industry and a growing interest in CAR-T Cell therapy among the investor community. Click image above to view full announcement. WBB Securities The WBB Research Institute is a research organization, founded by WBB Securities. The Institute focuses on emerging critical issues in healthcare that threaten to have profound impact. WBB Securities is a leading Investment Management, Investment Banking, and Equity Research firm focused on the life sciences. WBB Securities is registered with the SEC as a broker-dealer, a FINRA member firm, and a Registered Investment Advisor with a proprietary trading desk. The firm is comprised of a nationwide team of respected senior investment and research professionals serving institutional and high-net-worth clients. Contacts: Henry Bassman 9085229212 hbassman@wbbsec.com Source: WBB Securities To view the source version of this press release, please visit https://www.newsfilecorp.com/release/177588
Cranford, New Jersey--(Newsfile Corp. - August 17, 2023) - Marker Therapeutics (NASDAQ: MRKR) highlights its technology during a recently held, 75-minute Demi-Colton Virtual Salon/Webinar on cell therapy and CAR-T, a breakthrough cancer treatment that modifies a patient's own T cells to fight cancer. To view the full announcement, including downloadable images, bios, and more, click here. Key Takeaways: WBB Securities, an investment bank specializing in biotechnology, medical devices and life sciences, successfully organized a webinar focusing on the potential of Chimeric Antigen Receptor T-Cells (CAR-T) therapy in the future of cancer treatment. The webinar, organized by CEO Steve Brozak, DMH featured distinguished speakers and experts in the field of CAR-T Cell therapy who provided insights into the science behind the therapy, its clinical applications, and potential market growth. The positive response to the event underscores WBB Securities' role in connecting investors with key developments in the healthcare industry and a growing interest in CAR-T Cell therapy among the investor community. Click image above to view full announcement. WBB Securities The WBB Research Institute is a research organization, founded by WBB Securities. The Institute focuses on emerging critical issues in healthcare that threaten to have profound impact. WBB Securities is a leading Investment Management, Investment Banking, and Equity Research firm focused on the life sciences. WBB Securities is registered with the SEC as a broker-dealer, a FINRA member firm, and a Registered Investment Advisor with a proprietary trading desk. The firm is comprised of a nationwide team of respected senior investment and research professionals serving institutional and high-net-worth clients. Contacts: Henry Bassman 9085229212 hbassman@wbbsec.com Source: WBB Securities To view the source version of this press release, please visit https://www.newsfilecorp.com/release/177588